SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
222 hedge funds and large institutions have $176M invested in Sorrento Therapeutics, Inc. in 2022 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 74 increasing their positions, 49 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
15% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 40
32% less capital invested
Capital invested by funds: $260M → $176M (-$84.1M)
Holders
222
Holding in Top 10
1
Calls
$3.58M
Puts
$2.42M
Top Buyers
| 1 | +$8.83M | |
| 2 | +$6.22M | |
| 3 | +$4.65M | |
| 4 |
BRF
B. Riley Financial
Los Angeles,
California
|
+$4.62M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.91M |
Top Sellers
| 1 | -$1.24M | |
| 2 | -$1.2M | |
| 3 | -$1.11M | |
| 4 |
GCM
Graham Capital Management
Rowayton,
Connecticut
|
-$736K |
| 5 |
Citigroup
New York
|
-$686K |